公司資料
ImmunoGen 股價、新聞與催化劑
- 股票代碼:
- IMGN
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股價為何變動
Current closing-price context is not available for IMGN.
公司概覽
業務概覽
ImmunoGen was an antibody-drug conjugate company focused on oncology before being acquired by AbbVie.
所在地與產業分類
Headquartered in the United States and listed on NASDAQ prior to acquisition, it sat in oncology biotechnology.
商業模式特徵
The business was driven by ADC development, commercial execution, and the value of its tumor-targeting payload platform.
生技產業定位
ImmunoGen was one of the defining ADC names and now belongs to biotech M&A history.
未來催化劑
- ImmunoGen is now mainly a closeout / integration story after the AbbVie transaction, so the catalysts are any remaining corporate or settlement steps rather than a live pipeline event. The market is focused on residual value and final integration details.
近期新聞
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。